Loading...
Drs. Peter Neumann, Joshua Cohen, and Daniel Ollendorf — all of Tufts Medical Center's Center for the Evaluation of Value and Risk in Health — describe the economics of prescription drugs, how their value is measured under different systems, and how it might be possible to set prices based on that value.
In the U.S., people spend some $500 billion a year on prescription drugs, and their per capita spending is at least twice that of patients in the U.K.
Do you want to be notified whenever there is a new Clinical Conversations post? Sign up to receive notifications by email by using the Subscribe box.
Want to see more from NEJM Journal Watch? Register here.